Monday, April 13, 2026

📄 First Phase of Abstract Submission Closing Soon

The first phase of abstract submission for the Global Vaccines Innovation and Immunology Conference (GVX 2026) is closing soon. Researchers, scientists, healthcare professionals, and industry experts are invited to submit their work and contribute to advancing vaccine science.

Abstract submissions provide an opportunity to showcase innovative research, share scientific insights, and engage with a global network of experts in vaccinology and immunology.


🧬 Why Submit Your Abstract?

Submitting your abstract allows you to:

• Present your research at an international conference
• Gain recognition among global experts
• Contribute to scientific discussions in vaccine innovation
• Be part of conference proceedings with DOI publication (
vaccines.miconferences.com)

Accepted abstracts may be selected for oral or poster presentations, providing valuable exposure and networking opportunities.


📊 Important Deadline

The first phase of abstract submission is closing soon, so early submission is highly recommended to secure your participation. (vaccines.miconferences.com)


🌐 Conference Details

📅 September 21–23, 2026
📍 London, United Kingdom & Online

📄 Submit Your Abstract
https://vaccines.miconferences.com/abstract-submission

🔗 Event Website
https://vaccines.miconferences.com/

#GVX2026 #AbstractSubmission #Vaccines #Immunology #VaccineResearch #BiomedicalResearch #GlobalHealth #MedicalConference #HealthcareInnovation

No comments:

Post a Comment

👥 Group Registration Savings – Get 20% Off

Attend the Global Vaccines Innovation and Immunology Conference (GVX Immunology 2026) with your team and enjoy exclusive savings. Regist...